Afferent loop obstruction with pancreatitis after distal partial gastrectomy with B-II reconstruction added Braun anastomosis for cancer of the stomachNAKAO, Koji; FUJIWARA, Yoshinori; ITOH, Reiko et al.Hepato-gastroenterology. 2003, Vol 50, Num 51, pp 893-896, issn 0172-6390, 4 p.Article

Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancerTAKEDA, Masayuki; OKAMOTO, Isamu; HIRABAYASHI, Naoko et al.Lung cancer. 2011, Vol 73, Num 1, pp 103-109, issn 0169-5002, 7 p.Article

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancerYAMAMOTO, Nobuyuki; NISHIMURA, Yasumasa; NAKAGAWA, Kazuhiko et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 3, pp 285-291, issn 0344-5704, 7 p.Article

A new RHQT Nb₃Al superconducting wire with a Ta/Cu/Ta three-layer filament-barrier structureTAKEUCHI, Takao; TSUCHIYA, Kiyosumi; NAKAGAWA, Kazuhiko et al.Superconductor science & technology (Print). 2012, Vol 25, Num 6, issn 0953-2048, 065016.1-065016.8Article

Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumorsTAKAHASHI, Shunji; MIYAZAKI, Masaki; OKAMOTO, Isamu et al.Cancer science. 2011, Vol 102, Num 11, pp 2058-2064, issn 1347-9032, 7 p.Article

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor GrowthKANEDA, Hiroyasu; ARAO, Tokuzo; YAMADA, Yasuhide et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 5, pp 2053-2063, issn 0008-5472, 11 p.Article

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumorsSHIMIZU, Toshio; OKAMOTO, Isamu; TAMURA, Kenji et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 2, pp 243-250, issn 0344-5704, 8 p.Article

Phase i study of tzt-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week coursesTAMURA, Kenji; NAKAGAWA, Kazuhiko; FUKUOKA, Masahiro et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 2, pp 285-293, issn 0344-5704, 9 p.Article

Pemetrexed- induced edema of the eyelidKURATA, Takayasu; TAMURA, Kenji; OKAMOTO, Isamu et al.Lung cancer. 2006, Vol 54, Num 2, pp 241-242, issn 0169-5002, 2 p.Article

Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancerKANEDA, Hiroyasu; TAMURA, Kenji; KURATA, Takayasu et al.Lung cancer. 2004, Vol 46, Num 2, pp 247-254, issn 0169-5002, 8 p.Article

Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancerFUKUOKA, Masahiro; YANO, Seiji; EEK, Richard et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2237-2246, issn 0732-183X, 10 p.Article

A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancerHASEGAWA, Yoshikazu; OKAMOTO, Isamu; AZUMA, Koichi et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 599-604, issn 0167-6997, 6 p.Article

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancerOKUSAKA, Takuji; FURUSE, Junji; ITO, Tetsuhide et al.Cancer science. 2011, Vol 102, Num 2, pp 425-431, issn 1347-9032, 7 p.Article

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105YAMAMOTO, Nobuyuki; NAKAGAWA, Kazuhiko; SAWA, Toshiyuki et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3739-3745, issn 0732-183X, 7 p.Article

Strand and Cable Development for a High Field Nb₃Al Common Coil MagnetKIKUCHI, Akihiro; YAMADA, Ryuji; YAMAMOTO, Akira et al.IEEE transactions on applied superconductivity. 2010, Vol 20, Num 3, pp 1428-1431, issn 1051-8223, 4 p.Conference Paper

Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non-Small Cell Lung Cancer CellsIWASA, Tsutomu; OKAMOTO, Isamu; SUZUKI, Minoru et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5117-5125, issn 1078-0432, 9 p.Article

SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesionTANAKA, Kaoru; ARAO, Tokuzo; OKAMOTO, Isamu et al.International journal of cancer (Print). 2009, Vol 124, Num 5, pp 1072-1080, issn 0020-7136, 9 p.Article

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or ErkYOSHIDA, Takeshi; OKAMOTO, Isamu; OKABE, Takafumi et al.International journal of cancer. 2008, Vol 122, Num 7, pp 1530-1538, issn 0020-7136, 9 p.Article

Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancerOZAKI, Tomohiro; TAMURA, Kenji; SATOH, Taroh et al.Anticancer research. 2007, Vol 27, Num 4C, pp 2657-2665, issn 0250-7005, 9 p.Article

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinibYOSHIMURA, Naruo; KUDOH, Shinzoh; KIMURA, Tatsuo et al.Lung cancer. 2006, Vol 51, Num 3, pp 363-368, issn 0169-5002, 6 p.Article

Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancerYAMAMOTO, Nobuyuki; TSURUTANI, Junji; YOSHIMURA, Naruo et al.Anticancer research. 2006, Vol 26, Num 1B, pp 777-781, issn 0250-7005, 5 p.Article

Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-lb as a dominant antigen and its immunogenicity in lung adenocarcinomaELDIB, Ali Mohamed; ONO, Toshiro; SHIMONO, Michihide et al.International journal of cancer. 2004, Vol 108, Num 4, pp 558-563, issn 0020-7136, 6 p.Article

Mutational analysis of the β-tubulin gene in lung cancerTSURUTANI, Junji; KOMIYA, Takefumi; UEJIMA, Hisao et al.Lung cancer. 2002, Vol 35, Num 1, pp 11-16, issn 0169-5002Article

A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)HORINOUCHI, Hidehito; YAMAMOTO, Noboru; KANEDA, Hiroyasu et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 37-43, issn 0344-5704, 7 p.Article

Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancerKURATA, Takayasu; TSURUTANI, Junji; FUJISAKA, Yasuhito et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 946-954, issn 0167-6997, 9 p.Article